Evidence map›Paper›PMID 33691275›Full record

ArticleJournal of the National Comprehensive Cancer Network : JNCCN2021

Sociodemographic Factors Associated With Rapid Relapse in Triple-Negative Breast Cancer: A Multi-Institution Study.

Sarah Asad, Carlos H Barcenas, Richard J Bleicher, Adam L Cohen, Sara H Javid, Ellis G Levine, Nancy U Lin, Beverly Moy, Joyce Niland, Antonio C Wolff and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the National Comprehensive Cancer Network : JNCCN, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 1 country.

Sarah AsadOhio State University Wexner Medical Center, Columbus, Ohio.
Carlos H BarcenasMD Anderson Cancer Center, Houston, Texas.
Richard J BleicherFox Chase Cancer Center, Philadelphia, Pennsylvania.
Adam L CohenUniversity of Utah, Salt Lake City, Utah.
Sara H JavidSeattle Cancer Care Alliance, Seattle, Washington.
Ellis G LevineRoswell Park Comprehensive Cancer Center, Buffalo, New York.
Nancy U LinDana-Farber Cancer Institute, and.
Beverly MoyMassachusetts General Hospital, Boston, Massachusetts.
Joyce NilandCity of Hope National Medical Center, Duarte, California; and.
Antonio C WolffJohns Hopkins University, Baltimore, Maryland.
Michael J HassettDana-Farber Cancer Institute, and.
Daniel G StoverOhio State University Wexner Medical Center, Columbus, Ohio.
Dana-Farber Cancer Institute · USThe Ohio State University Wexner Medical Center · USCity Of Hope National Medical Center · USFox Chase Cancer Center · USMassachusetts General Hospital · USRoswell Park Comprehensive Cancer Center · USSeattle Cancer Care Alliance · USThe University of Texas MD Anderson Cancer Center · USUniversity of Utah · US

Funding

NCI NIH HHS L30 CA189226
6 · The paper itself

Abstract

backgroundTriple-negative breast cancer (TNBC) accounts for disproportionately poor outcomes in breast cancer, driven by a subset of rapid-relapse TNBC (rrTNBC) with marked chemoresistance, rapid metastatic spread, and poor survival. Our objective was to evaluate clinicopathologic and sociodemographic features associated with rrTNBC.

methodsWe included patients diagnosed with stage I-III TNBC in 1996 through 2012 who received chemotherapy at 1 of 10 academic cancer centers. rrTNBC was defined as a distant metastatic recurrence event or death ≤24 months after diagnosis. Features associated with rrTNBC were included in a multivariable logistic model upon which backward elimination was performed with a P<.10 criterion, with a final multivariable model applied to training (70%) and independent validation (30%) cohorts.

resultsAmong all patients with breast cancer treated at these centers, 3,016 fit the inclusion criteria. Training cohort (n=2,112) bivariable analyses identified disease stage, insurance type, age, body mass index, race, and income as being associated with rrTNBC (P<.10). In the final multivariable model, rrTNBC was significantly associated with higher disease stage (adjusted odds ratio for stage III vs I, 16.0; 95% CI, 9.8-26.2; P<.0001), Medicaid/indigent insurance, lower income (by 2000 US Census tract), and younger age at diagnosis. Model performance was consistent between the training and validation cohorts. In sensitivity analyses, insurance type, low income, and young age were associated with rrTNBC among patients with stage I/II but not stage III disease. When comparing rrTNBC versus late relapse (>24 months), we found that insurance type and young age remained significant.

conclusionsTiming of relapse in TNBC is associated with stage of disease and distinct sociodemographic features, including insurance type, income, and age at diagnosis.

Indexed as

Breast NeoplasmsTriple Negative Breast NeoplasmsCohort StudiesFemaleHumansNeoplasm Recurrence, LocalNeoplasm StagingOdds RatioSociodemographic Factors

Identifiers

PMID33691275
PMCPMC8564718
OpenAlexW3134645426

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.